May Bakir

Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE)

S. Reis, L. Shaw, S. Kelsey, 2020, International journal of cardiology. Heart & vasculature.

LATE GADOLINIUM ENHANCEMENT AND ADVERSE CARDIAC EVENTS AT 1 YEAR FOLLOW-UP IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY DISEASE: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION

D. Berman, S. Kelsey, C. Pepine, 2015 .

Sex and gender medicine in physician clinical training: results of a large, single-center survey

C. Merz, S. Dhawan, E. Jones, 2016, Biology of Sex Differences.

Managing Ischemic Heart Disease in Women: Role of a Women’s Heart Center

A. Volgman, Abha Khandelwal, Melissa J. Tracy, 2021, Current Atherosclerosis Reports.

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study

C. Pepine, G. Sopko, E. Handberg, 2020, PloS one.

Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.

D. Berman, S. Kelsey, C. Pepine, 2018, Circulation.

Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.

C. Pepine, G. Sopko, B. Sharif, 2016, International journal of cardiology.

Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.

Piotr J Slomka, Debiao Li, Erika Jones, 2016, Cardiovascular diagnosis and therapy.